Introduction
technology, based on fast electron computed tomography (CT ) led to the recognition that the number For decades, it has been known that patients with endand the extension of calcified plaques [7] is a highly stage renal failure have an excessive coronary and sensitive indicator of coronary atherosclerosis. The cardiac risk. There is also widespread consensus that specificity of the lesions detected by fast electron CT coronary atherosclerosis and its complications are not is shown by the fact that they respond to interventions fully explained by classical risk factors, e.g. dyslipidaesuch as administration of statins [8] . Necrotic cores of mia, elevated homocysteine concentrations, hypertenplaques are known to calcify easily. This is accompansion, insulin resistance, high fibrinogen etc.
ied by expression of genes which potentially play a Studies on uraemia spring many surprises. In an role in calcium metabolism, e.g. osteopontin and osteoearly investigation, the paradoxical finding had been calcin, raising interesting issues about the mechanisms, made [1] that high cholesterol concentrations are direct or indirect, through which hyperphosphataemia predictive of better survival. This observation subpromotes calcification. Autopsy studies [9] and clinical sequently has been confirmed [2] and the paradox observations using electron-beam CT [10] showed a is presumably explained by the fact that high choleshigh prevalence of rapidly progressing calcified coronterol is a surrogate marker for adequate nutrition.
ary plaques in uraemic patients. These findings with Conversely, malnutrition turned out to be highly preimaging procedures are supported by our own observadictive of death including cardiac death [3] .
tions [11] . Figure 1 shows the heart of an uraemic Block et al. [4] sprang another surprise on the patient with heavy calcification of the aortic valve and nephrological community when they found that hyperthe aorta ascendens. Figure 2 shows a characteristic phosphataemia predicted reduced survival. This was calcified coronary artery of an uraemic patient. accounted for by an excess of cardiac death. This Figure 3 shows the histology of a calcified coronary observation has been confirmed and extended plaque. When comparing coronary plaques in 27 recently [5] .
In the following, we discuss several possibilities of how elevated serum phosphate concentration may aggravate the cardiac risk and the impact that those observations will have on patient management.
Hyperphosphataemia and coronary plaques
Coronary plaques are not static lesions, but highly dynamic structures. They are initiated by injury to or dysfunction of the endothelial cell layer, migration of activated monocytes and local interaction with proliferating vascular smooth muscle cells. This sequence of injury and repair may occur on multiple occasions. The final outcome, i.e. stabilization or rupture with coronary thrombosis, will depend on the interplay between collagen fibre deposition (fibrous cap) on the one hand and proteolytic activity, released by activated macrophages and vascular smooth muscle cells, on the other hand [6 ] . Calcification is a feature of an advanced [14, 15] . This consideration would give another twist to the proposal of Massry that PTH is a potential cardiac and vascular 'toxin' [16 ] . A direct effect is a plausible possibility, however, in view of the observation that serum phosphate is correlated to angiographic levels of coronary disease and coronary occlusion in non renal patients [17] . In the past, we had studied a model of renal failure, i.e. the subtotally nephrectomized rat, and found that parathyroidectomy prevented, and infusion of the rat 1-34 N-terminal PTH fragment restored activation of interstitial cells [18] and thickening of the wall of cardiac arterioles [19]. Recently, we studied interstitial fibrosis and arteriolar wall thickness in the heart and noted striking differences between subtotally nephrectomized animals put on low phosphate compared with high phosphate diet [20] ; currently, we cannot exclude the possiblity that this finding is explained by differences in PTH.
In summary, hyperphosphataemia may adversely affect cardiac prognosis, first by modifying coronary plaque morphology, but, second, also by affecting the structure of the heart including the microvasculature. This would add an element of post-coronary microvascular disease with obvious repercussions on ischaemia tolerance [11] . These direct effects on the heart may be complemented by hyperphosphataemia-induced alterations in the elastic arteries, as suggested by the observation of London reported in this issue [21] . Since diminished aortic elasticity imposes greater work load upon the heart of the uraemic patient [22] , it will preliminary findings in his cross-sectional observational study. uraemic and 27 non-uraemic patients, the proportion of calcified plaques was 67 and 18%, respectively. Obviously, apart from the known adverse effects of Clinical implications hyperphosphlataemia on calcification of the aortic valves ( Figure 1 ) and the mitral annulus [12], calciWhere does all this leave us today? fication of coronary plaques induced by hyperphosphataemia may also aggravate the cardiac risk of As discussed above, it remains unclear whether phosdialysed patients. Before one accepts this proposal as phate is injurious per se or whether the adverse effect the explanation for the above epidemiological findings is mediated via PTH. At any rate, it is appropriate [4, 5] , one has, however, to exclude several con-that every effort is made to keep serum phosphate founding factors.
concentration and PTH concentration within or close to the normal range respectively. The recognition that hyperphosphataemia increases the cardiac risk gives
Potential mechanisms of cardiac changes induced
an entirely new urgency to hyperphosphataemia conby hyperphosphataemia trol. The magnitude of the risk is illustrated by the fact that hyperphosphataemic compared with normophosphataemic patients have a 52% higher risk of Hyperphosphataemia may well be a surrogate marker of suboptimal dialysis. Conversely, more intense dia-death from coronary artery disease, a 26% higher risk of sudden death, a 34% higher risk from other cardiac lysis treatment, particularly more frequent dialysis sessions, lowers phosphate in a dramatic fashion, so causes and a 39% higher risk of death from cerebrovascular accidents [5] . From the patients' perspective, that some patients may even develop hypophosphataemia [13] . Inadequate dialysis (underdialysis) may prevention of cardiac death is far more important than prevention of renal osteodystrophy, which in the past promote cardiac death by mechanisms other than hyperphosphataemia such as hypervolaemia, poor con-has dominated the nephrologists' perception of why hyperphosphataemia is dangerous. trol of blood pressure, malnutrition etc.
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